200 related articles for article (PubMed ID: 33767401)
1. Prognostic impact of the adverse molecular-genetic profile on long-term outcomes following allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.
Daher-Reyes G; Kim T; Novitzky-Basso I; Kim KH; Smith A; Stockley T; Capochichi JM; Al-Shaibani Z; Pasic I; Law A; Lam W; Michelis FV; Gerbitz A; Viswabandya A; Lipton J; Kumar R; Mattsson J; Schimmer A; McNamara C; Murphy T; Maze D; Gupta V; Sibai H; Chan S; Yee K; Minden M; Zhang Z; Schuh A; Kim DDH
Bone Marrow Transplant; 2021 Aug; 56(8):1908-1918. PubMed ID: 33767401
[TBL] [Abstract][Full Text] [Related]
2. Complex karyotype but not other cytogenetic abnormalities is associated with worse posttransplant survival of patients with nucleophosmin 1-mutated acute myeloid leukemia: A study from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party.
Moukalled N; Labopin M; Versluis J; Socié G; Blaise D; Salmenniemi U; Rambaldi A; Gedde-Dahl T; Tholouli E; Kröger N; Bourhis JH; Von Dem Borne P; Daguindau E; Forcade E; Nagler A; Esteve J; Ciceri F; Bazarbachi A; Mohty M
Am J Hematol; 2024 Mar; 99(3):360-369. PubMed ID: 38165072
[TBL] [Abstract][Full Text] [Related]
3. DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation.
Ahn JS; Kim HJ; Kim YK; Lee SS; Jung SH; Yang DH; Lee JJ; Kim NY; Choi SH; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Kim SH; Kim DD
Biol Blood Marrow Transplant; 2016 Jan; 22(1):61-70. PubMed ID: 26234722
[TBL] [Abstract][Full Text] [Related]
4. Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT.
Brands-Nijenhuis AV; Labopin M; Schouten HC; Volin L; Socié G; Cornelissen JJ; Huynh A; Ljungman P; Malard F; Esteve J; Nagler A; Mohty M
Haematologica; 2016 Feb; 101(2):248-55. PubMed ID: 26589909
[TBL] [Abstract][Full Text] [Related]
5. FLT3-ITD Compared with DNMT3A R882 Mutation Is a More Powerful Independent Inferior Prognostic Factor in Adult Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study.
Ardestani MT; Kazemi A; Chahardouli B; Mohammadi S; Nikbakht M; Rostami S; Jalili M; Vaezi M; Alimoghaddam K; Ghavamzadeh A
Turk J Haematol; 2018 Aug; 35(3):158-167. PubMed ID: 29786546
[TBL] [Abstract][Full Text] [Related]
6. Impact of FLT3 internal tandem duplication and NPM1 mutations in acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation.
Khanolkar RA; Faridi RM; Kinzel M; Jamani K; Savoie ML; Shafey M; Khan FM; Storek J
Cytotherapy; 2022 Apr; 24(4):413-420. PubMed ID: 34863627
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic hematopoietic cell transplantation may alleviate the negative prognostic impact of monosomal and complex karyotypes on patients with acute myeloid leukemia.
Guo RJ; Atenafu EG; Craddock K; Chang H
Biol Blood Marrow Transplant; 2014 May; 20(5):690-5. PubMed ID: 24492143
[TBL] [Abstract][Full Text] [Related]
8. Monosomal karyotype affecting outcomes of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission.
Choi Y; Lee JH; Lee JH; Park HS; Choi EJ; Jo JC; Lee YJ; Lee YS; Kang YA; Lee KH
Eur J Haematol; 2020 Sep; 105(3):262-273. PubMed ID: 32353911
[TBL] [Abstract][Full Text] [Related]
9. Independent prognostic significance of TP53 mutations in adult acute myeloid leukaemia with complex karyotype.
Xu N; Lai YY; Chen WM; Jiang H; Wang Y; Wang X; Zhao XS; Huang XJ; Jiang Q; Qin YZ
Int J Lab Hematol; 2022 Oct; 44(5):892-899. PubMed ID: 35505580
[TBL] [Abstract][Full Text] [Related]
10. Mutational profile, outcomes, and impact of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia and inconclusive cytogenetic analysis.
Vasudevan Nampoothiri R; Tang K; Schuh A; Lam W; Maze D; Michelis FV; Chan S; Gupta V; Kim D; Kumar R; Lipton JH; Mattsson J; Minden M; Schimmer A; Sibai H; Viswabandya A; Yee K; Murphy T; Law AD
Eur J Haematol; 2023 Jun; 110(6):618-625. PubMed ID: 36732677
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of complex and/or monosomal karyotypes in post-transplant poor cytogenetic acute myeloid leukaemia: A quantitative approach.
Jo T; Arai Y; Oshima S; Kondo T; Harada K; Uchida N; Doki N; Fukuda T; Tanaka M; Ozawa Y; Kuriyama T; Ikegame K; Katayama Y; Ota S; Ara T; Kawakita T; Onizuka M; Ichinohe T; Atsuta Y; Yanada M;
Br J Haematol; 2023 Jul; 202(2):356-368. PubMed ID: 37211753
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic risk grouping by the monosomal karyotype classification is superior in predicting the outcome of acute myeloid leukemia undergoing allogeneic stem cell transplantation in complete remission.
Hemmati PG; Schulze-Luckow A; Terwey TH; le Coutre P; Vuong LG; Dörken B; Arnold R
Eur J Haematol; 2014 Feb; 92(2):102-10. PubMed ID: 24138573
[TBL] [Abstract][Full Text] [Related]
13. Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant.
Ahn JS; Kim JY; Kim HJ; Kim YK; Lee SS; Jung SH; Yang DH; Lee JJ; Kim NY; Choi SH; Minden MD; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Kim SH; Kim DD
Ann Hematol; 2016 Jan; 95(2):301-10. PubMed ID: 26537612
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of adult patients with acute myeloid leukemia and unsuccessful cytogenetic analysis undergoing allogeneic hematopoietic stem cell transplantation.
Vasudevan Nampoothiri R; Chen S; Pasic I; Al-Shaibani Z; Lam W; Michelis FV; Kim DDH; Viswabandya A; Gerbitz A; Lipton JH; Kumar R; Mattsson J; Law AD
Hematol Oncol Stem Cell Ther; 2021 Jun; 14(2):134-140. PubMed ID: 33049225
[TBL] [Abstract][Full Text] [Related]
15. Monosomal karyotype provides better prognostic prediction after allogeneic stem cell transplantation in patients with acute myelogenous leukemia.
Oran B; Dolan M; Cao Q; Brunstein C; Warlick E; Weisdorf D
Biol Blood Marrow Transplant; 2011 Mar; 17(3):356-64. PubMed ID: 20553926
[TBL] [Abstract][Full Text] [Related]
16. Measurable residual disease, FLT3-ITD mutation, and disease status have independent prognostic influence on outcome of allogeneic stem cell transplantation in NPM1-mutated acute myeloid leukemia.
Al Hamed R; Labopin M; Daguindau E; Niittyvuopio R; Huynh A; Socié G; Srour M; Henri Bourhis J; Kröger N; Tholouli E; Choi G; Poiré X; Martin H; Rubio MT; Jindra P; Blaise D; Beelen D; Labussière-Wallet H; Nagler A; Bazarbachi A; Mohty M
Cancer Med; 2022 Feb; 11(4):1068-1080. PubMed ID: 35048553
[TBL] [Abstract][Full Text] [Related]
17. Outcomes for Patients With IDH-Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.
Chen EC; Li S; Eisfeld AK; Luskin MR; Mims A; Jones D; Antin JH; Cutler CS; Koreth J; Ho VT; Gooptu M; Romee R; El-Jawahri A; McAfee SL; DeFilipp Z; Soiffer RJ; Chen YB; Fathi AT
Transplant Cell Ther; 2021 Jun; 27(6):479.e1-479.e7. PubMed ID: 33840625
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic stem cell transplantation using HLA-matched donors for acute myeloid leukemia with deletion 5q or monosomy 5: a study from the Acute Leukemia Working Party of the EBMT.
Poiré X; Labopin M; Polge E; Forcade E; Ganser A; Volin L; Michallet M; Blaise D; Yakoub-Agha I; Maertens J; Espiga CR; Cornelissen J; Finke J; Mohty M; Esteve J; Nagler A
Haematologica; 2020; 105(2):414-423. PubMed ID: 31048355
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients with monosomal karyotypes.
Moon JH; Lee YJ; Seo SK; Han SA; Yoon JS; Ham JY; Suh JS; Sohn SK
Acta Haematol; 2015; 133(4):327-35. PubMed ID: 25503503
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of TP53 mutation, monosomal karyotype, and prior myeloid disorder in nonremission acute myeloid leukemia at allo-HSCT.
Najima Y; Sadato D; Harada Y; Oboki K; Hirama C; Toya T; Doki N; Haraguchi K; Yoshifuji K; Akiyama M; Inamoto K; Igarashi A; Kobayashi T; Kakihana K; Okuyama Y; Sakamaki H; Harada H; Ohashi K
Bone Marrow Transplant; 2021 Feb; 56(2):334-346. PubMed ID: 32760007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]